This is an HTML version of an attachment to the Official Information request 'Independent Monitoring Safety Board'.




133 Molesworth Street 
PO Box 5013 
Wellington 6140 
New Zealand 
T+64 4 496 2000 
9 February 2022
Chuck Schooner 
By email:  [FYI request #18024 email] 
Ref:   
H202200478 
Tēnā koe Chuck 
Response to your request for official information 
Thank you for your requests under the Official Information Act 1982 (the Act) on 21, 22, 23 and 
30 December 2021, which have been consolidated into one response to reduce the 
administrative burden. I shall respond to each parts of your request below:  
Please provide the salaries of all of the safety board and what the cost to the taxpayer is 
The level of attendance fees are set in accordance with Cabinet Office Circular CO (12) 6, fees 
framework for members appointed to bodies in which the Crown has an interest. 
Further information can be found here: https://dpmc.govt.nz/publications/co-19-1-fees-
framework-members-appointed-bodies-which-crown-has-interest-html#section-
6https:/ dpmc.govt.nz/publications/co-19-1-fees-framework-members-appointed-bodies-which-
crown-has-interest-html.  
The Group level and fee is as follows: 
• Group 4, Level 1
• Chair fee is $1,150 (daily rate)
Am I correct in saying if a death is reported due to the vaccine then in 3 years the coroner 
wil  know the answer. To date there are 117 deaths and over a 1,000 within 21 days of 
vaccine. So in three years we wil  likely see another 300 plus deaths at this rate and then 
the coroner might be able to make a judgement on one? So in that time 300 more people 
lose there lives? 
Please refer to the following media statements from the Ministry for further information on this:    

Link to the media statement from 30 August 2021: https://www.health.govt.nz/news-
media/media-releases/clinicians-reminded-be-aware-myocarditis-and-pericarditis-
symptoms

Link to the media statement from 20 December 2021: https://www.health.govt.nz/
news-media/media-releases/statement-covid-19-vaccine-independent-safety-
monitoring-board 

You recently announced a warning not to use Goree Beauty cream due to mercury and 
lead in the products which may have toxic effects on the nervous, digestive and immune 
systems, and on the lungs, kidneys, skin and eyes. It can also affect the development of 
unborn babies. Please provide all evidence/reports and the decision making process 
behind this warning. How many known reported side effects that you mention have 
occurred from the use of Goree Beauty cream? 
Medsafe has received one report of a poisoning event in connection with the use of this product. 
Medsafe is aware of one other report linking this product with an adverse reaction.  Note that as 
the cream is marketed as a cosmetic, adverse events are less likely to be reported through 
Medsafe systems. The profile of adverse events connected with high levels of mercury and lead 
are well-established. Medsafe based its alert on this evidence and the fact that the product was 
being marketed il egally in New Zealand and had been connected with adverse events. 
The Pfizer vaccine has al  of these side effects in significant numbers. Why the double 
standard? If this is the standard for Goree Beauty then why isn’t the same standard 
applied to Pfizer. Please provide a comparison of adverse affects Goree Beauty versus 
Pfizer. 
While the Act allows New Zealanders to ask for information from Ministers and government 
agencies, there is no requirement for agencies to create new information, compile information 
they do not hold or provide or prove an opinion. As you have been advised previously, your 
questions and the statements that support them appear designed to engage in a debate about 
the Government’s COVID-19 vaccination programme, rather than a request for official 
information. The Act does not support requests where an opinion, comment, argument, or 
hypothetical statement is put to the Ministry for response, couched as a request for information. 
These questions are therefore refused under section 18(g) of the Act on the grounds that the 
information sought is not held by the Ministry. 
Please provide the forecast “expected deaths” in the age groups of 5-20 in the coming 
year. 
COVID-19 modelling is publicly available online at the following address: 
https:/ www.tepunahamatatini.ac.nz/covid-19/.  
Can you please confirm if any of these deaths whilst isolating at home occurred within 21 
days of the deceased receiving a first or second shot of the experimental gene therapy? If 
the answer is yes then where have their deaths been recorded? With Covid? 
Put in the observed versus expected deaths? 
Recorded as a vaccine death? 
Have these been double counted anywhere? Prior to mass vaccinations over 99% of 
people recovered and people generally had time to seek medical attention. So I’m 
assuming these deaths at home related to sudden events. Please provide the cause of 
death - cardiac, stroke, embolism etc 
Are refugees residing in New Zealand receiving the Pfizer experimental gene therapy? If 
not does the Pfizer contract the NZ Government signed preclude vaccines for refugees 
due to potential litigation against Pfizer as is the case overseas? 
Anyone in New Zealand is able to get vaccinated. As you have been advised on multiple 
occasions, the Pfizer Comirnaty vaccine is not gene therapy. The Ministry is therefore refusing 
the remainder of this part of your request under section 18(h) as it is vexatious. 
Page 2 of 3 


The CDC in the US wil  withdraw the PCR test because it cannot differentiate between the 
flu and Covid-19 How is the Ministry of Health determining cases in New Zealand?  
Is it via PCR tests? 
If so then every single policy being implemented based on high case numbers via PCR 
testing is flawed. 
How many flu cases in NZ in 2021? Zero? 
Flu reports can be found online at the following link: https://info.flutracking.net/reports-2/new-
zealand-reports/. 
The Ministry does not accept the premise of these questions which are based on 
misinformation. The Ministry has responded to similar questions several times. In particular, I 
want to draw your attention to the responses to questions 14 to 17 of this response published 
at: www.health.govt.nz/system/files/documents/information-release/h202111151_response.pdf. 
Under section 28(3) of the Act, you have the right to ask the Ombudsman to review any 
decisions made under this request. The Ombudsman may be contacted by email at: 
[email address] or by calling 0800 802 602. 
Please note that this response, with your personal details removed, may be published on the 
Ministry website at: www.health.govt.nz/about-ministry/information-releases. 
Nāku noa, nā 
Jan Torres 
Acting Manager, OIA Services 
Office of the Deputy Director-General 
Page 3 of 3